A pilot study on the use of divalproex sodium in the treatment of behavioral agitation in elderly patients with dementia: assessment with the behave-ad and CGI rating scales

1997 ◽  
Vol 58 (12) ◽  
pp. 981-989 ◽  
Author(s):  
John W. Kasckow ◽  
Susan L. McElroy ◽  
Renee L. Cameron ◽  
Leslie L. Mahler ◽  
Stanley J. Fudala
2021 ◽  
Vol 7 ◽  
pp. 205520762110012
Author(s):  
John E Leikauf ◽  
Carlos Correa ◽  
Andrew N Bueno ◽  
Vicente Peris Sempere ◽  
Leanne M Williams

Introduction To address the need for non-pharmacologic, scalable approaches for managing attention-deficit and hyperactivity disorder (ADHD) in young people, we report the results of a study of an application developed for a wearable device (Apple Watch) that was designed to track movement and provide visual and haptic feedback for ADHD. Methods Six-week, open label pilot study with structured rating scales ADHD and semi-structured qualitative interview. Apple Watch software application given to users that uses actigraphy and graphic interface as well as haptic feedback to provide feedback to users about level of movement during periods of intentional focus. Linear mixed models to estimate trajectories. Results Thirty-two participants entered the study. This application was associated with improvement in ADHD symptoms over the 6 weeks of the study. We observed an ADHD-Rating Scale change of β = −1.2 units/week (95% CI = −0.56 to −1.88, F = 13.4, P = .0004). Conclusions These positive clinical outcomes highlight the promise of such wearable applications for ADHD and the need to pursue their further development.


2010 ◽  
Vol 24 (7) ◽  
pp. 614-622 ◽  
Author(s):  
JJ Dronkers ◽  
H. Lamberts ◽  
IMMD Reutelingsperger ◽  
RH Naber ◽  
CM Dronkers-Landman ◽  
...  

2011 ◽  
Vol 20 (2) ◽  
pp. 135-138 ◽  
Author(s):  
Olga Kharevich ◽  
Barry Shipman ◽  
Barry M. Goldman ◽  
Max Nahon
Keyword(s):  

1968 ◽  
Vol 13 (2) ◽  
pp. 175-179
Author(s):  
J. Filotto ◽  
J.-M. Bordeleau ◽  
L. Tetreault

Nine manic patients have been the subjects of a pilot study with a new thioxanthene derivative, thiothixene. Data obtained from two rating scales indicate a significant improvement of the mental and behavioural conditions after three weeks of treatment. Thiothixene like other well-known neuroleptics induces extra-pyramidal symptoms and this tends to confirm the fact that thiothixene is a neuroleptic. The drug was well tolerated; however, we observed a decrease of prothrombin time in four patients.


2017 ◽  
Vol 16 (3) ◽  
pp. e1180
Author(s):  
T. Silvestri ◽  
N. Pavan ◽  
G. Chiapparrone ◽  
F. Vedovo ◽  
G. Di Cosmo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document